SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- Metabasis Therapeutics today announced that the Company will host a conference call and live webcast on Thursday, May 3, 2007 at 1:30 p.m. Pacific Time to discuss its financial results for the first quarter of 2007. Dr. Paul Laikind, president and chief executive officer and Mr. John Beck, senior vice president of finance and chief financial officer, will participate in the call.
The conference call may be accessed by dialing 800-638-5495 for domestic callers and 617-614-3946 for international callers. Please specify to the operator that you would like to join the "Metabasis First Quarter 2007 Financial Results Conference Call." The conference call will be webcast live on the Metabasis website at www.mbasis.com, under the Investors section, and will be archived there for 30 days following the call. Please connect to Metabasis' website several minutes prior to the start of the call to ensure adequate time for any software download that may be necessary.
About Metabasis (http://www.mbasis.com):
Metabasis Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs to address some of the world's most widespread and costly chronic diseases. By applying our proprietary technologies and scientific expertise, including unique capabilities for targeting the liver and liver pathways, the Company has established a pipeline that includes preclinical and clinical product candidates targeting metabolic diseases such as diabetes, hyperlipidemia and obesity, as well as liver diseases such as hepatitis and primary liver cancer. Metabasis has developed several proprietary technologies for use in discovering and optimizing drugs, including the NuMimetic(TM) and HepDirect(R) technologies. Metabasis is continuing to identify and develop new product candidates using its proprietary technologies and expertise.
Metabasis Therapeutics, Inc.CONTACT: Constance Bienfait, Vice President, Investor Relations &Corporate Communications of Metabasis Therapeutics, Inc., +1-858-622-5575
Web site: http://www.mbasis.com/
